130 related articles for article (PubMed ID: 24724423)
1. [Effects of four bisphosphonates on macrophage phagocytosis: quantitative measurement by flow cytometry using high-fluorescence particles and human monocytic cell line THP-1].
Imoto S; Saigo K; Bohgaki M; Matsumoto E; Goto M
Rinsho Byori; 2014 Jan; 62(1):23-30. PubMed ID: 24724423
[TBL] [Abstract][Full Text] [Related]
2. The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells.
Ishtiaq S; Edwards S; Sankaralingam A; Evans BA; Elford C; Frost ML; Fogelman I; Hampson G
Cytokine; 2015 Feb; 71(2):154-60. PubMed ID: 25461393
[TBL] [Abstract][Full Text] [Related]
3. Alteration of macrophage viability, differentiation, and function by bisphosphonates.
Patntirapong S; Poolgesorn M
Oral Dis; 2018 Oct; 24(7):1294-1302. PubMed ID: 29869362
[TBL] [Abstract][Full Text] [Related]
4. Altered macrophagic THP-1 cell phagocytosis and migration in bisphosphonate-related osteonecrosis of the jaw (BRONJ).
Hoefert S; Sade Hoefert C; Munz A; Northoff H; Yuan A; Reichenmiller K; Reinert S; Grimm M
Clin Oral Investig; 2016 Jun; 20(5):1043-54. PubMed ID: 26349768
[TBL] [Abstract][Full Text] [Related]
5. Zoledronate but not denosumab suppresses macrophagic differentiation of THP-1 cells. An aetiologic model of bisphosphonate-related osteonecrosis of the jaw (BRONJ).
Hoefert S; Hoefert CS; Albert M; Munz A; Grimm M; Northoff H; Reinert S; Alexander D
Clin Oral Investig; 2015 Jul; 19(6):1307-18. PubMed ID: 25411080
[TBL] [Abstract][Full Text] [Related]
6. Effect of bisphosphonates on macrophagic THP-1 cell survival in bisphosphonate-related osteonecrosis of the jaw (BRONJ).
Hoefert S; Sade Hoefert C; Munz A; Schmitz I; Grimm M; Yuan A; Northoff H; Reinert S; Alexander D
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Mar; 121(3):222-32. PubMed ID: 26725718
[TBL] [Abstract][Full Text] [Related]
7. The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes--in vitro study.
Pabst AM; Ziebart T; Koch FP; Taylor KY; Al-Nawas B; Walter C
Clin Oral Investig; 2012 Feb; 16(1):87-93. PubMed ID: 21225298
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitro.
Walter C; Pabst A; Ziebart T; Klein M; Al-Nawas B
Oral Dis; 2011 Mar; 17(2):194-9. PubMed ID: 20796232
[TBL] [Abstract][Full Text] [Related]
9. Phosphonocarboxylates Can Protect Mice against the Inflammatory and Necrotic Side Effects of Nitrogen-Containing Bisphosphonates by Inhibiting Their Entry into Cells via Phosphate Transporters.
Kiyama T; Tsuchiya M; Okada S; Oizumi T; Yamaguchi K; Sasaki K; Sugawara S; Endo Y
Biol Pharm Bull; 2016; 39(5):712-20. PubMed ID: 27150143
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates: Pharmacokinetics, bioavailability, mechanisms of action, clinical applications in children, and effects on tooth development.
Soares AP; do Espírito Santo RF; Line SR; Pinto Md; Santos Pde M; Toralles MB; do Espírito Santo AR
Environ Toxicol Pharmacol; 2016 Mar; 42():212-7. PubMed ID: 26895384
[TBL] [Abstract][Full Text] [Related]
11. In vitro effects of bisphosphonates on chemotaxis, phagocytosis, and oxidative burst of neutrophil granulocytes.
Hagelauer N; Pabst AM; Ziebart T; Ulbrich H; Walter C
Clin Oral Investig; 2015 Jan; 19(1):139-48. PubMed ID: 24668343
[TBL] [Abstract][Full Text] [Related]
12. Effects of bisphosphonates on human esophageal squamous cell carcinoma cell survival.
Minegaki T; Fukushima S; Morioka C; Takanashi H; Uno J; Tsuji S; Yamamoto S; Watanabe A; Tsujimoto M; Nishiguchi K
Dis Esophagus; 2016 Aug; 29(6):656-62. PubMed ID: 25894100
[TBL] [Abstract][Full Text] [Related]
13. Alendronate attenuates eosinophilic airway inflammation associated with suppression of Th2 cytokines, Th17 cytokines, and eotaxin-2.
Sasaki O; Imamura M; Yamazumi Y; Harada H; Matsumoto T; Okunishi K; Nakagome K; Tanaka R; Akiyama T; Yamamoto K; Dohi M
J Immunol; 2013 Sep; 191(6):2879-89. PubMed ID: 23935198
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory Effects of Nitrogen-Containing Bisphosphonates (N-BPs): Modulation by Non-N-BPs.
Shima K; Tsuchiya M; Oizumi T; Takano-Yamamoto T; Sugawara S; Endo Y
Biol Pharm Bull; 2017; 40(1):25-33. PubMed ID: 28049945
[TBL] [Abstract][Full Text] [Related]
15. In vitro toxicity of bisphosphonates on human neuroblastoma cell lines.
Vorotnjak M; Boos J; Lanvers-Kaminsky C
Anticancer Drugs; 2004 Sep; 15(8):795-802. PubMed ID: 15494642
[TBL] [Abstract][Full Text] [Related]
16. Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism.
Otto S; Pautke C; Opelz C; Westphal I; Drosse I; Schwager J; Bauss F; Ehrenfeld M; Schieker M
J Oral Maxillofac Surg; 2010 Nov; 68(11):2837-45. PubMed ID: 20971371
[TBL] [Abstract][Full Text] [Related]
17. Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro.
Idris AI; Rojas J; Greig IR; Van't Hof RJ; Ralston SH
Calcif Tissue Int; 2008 Mar; 82(3):191-201. PubMed ID: 18259679
[TBL] [Abstract][Full Text] [Related]
18. Physiology of the aging bone and mechanisms of action of bisphosphonates.
Dominguez LJ; Di Bella G; Belvedere M; Barbagallo M
Biogerontology; 2011 Oct; 12(5):397-408. PubMed ID: 21695491
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of phosphate transporters ameliorates the inflammatory and necrotic side effects of the nitrogen-containing bisphosphonate zoledronate in mice.
Okada S; Kiyama T; Sato E; Tanaka Y; Oizumi T; Kuroishi T; Takahashi T; Sasaki K; Sugawara S; Endo Y
Tohoku J Exp Med; 2013 Oct; 231(2):145-58. PubMed ID: 24140868
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonates do not inhibit periosteal bone formation in estrogen deficient animals and allow enhanced bone modeling in response to mechanical loading.
Feher A; Koivunemi A; Koivunemi M; Fuchs RK; Burr DB; Phipps RJ; Reinwald S; Allen MR
Bone; 2010 Jan; 46(1):203-7. PubMed ID: 19857619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
